Veritas Capital

Ramzi Musallam, CEO and Managing Partner, holds final authority over all investment decisions. He has led the firm since 2012 and worked at Veritas since 1997. The investment committee is compact—Musallam, Managing Partner Hugh Evans, and a small group of senior partners review every deal. Musallam's path from associate to CEO over 15 years is unusual in a sector where founders often resist succession (per public record).

Veritas invests exclusively in companies with significant government revenue—the firm's portfolio businesses sell primarily to defense, intelligence, and civilian agencies, not the commercial sector. This focus produces a regulatory moat: portfolio companies hold security clearances, operate classified facilities, and face CFIUS scrutiny on any exit. Generalist technology funds rarely have the clearance infrastructure or government-relationship networks to compete for these assets on equal terms.

Veritas Capital Fund VIII closed at $10.65 billion in 2022, exceeding its initial $8.5 billion target, according to a Bloomberg report at the time. This was the largest fund in the firm's 30-year history and roughly 50% larger than the $6.5 billion Fund VII raised in 2019. The firm does not publicly disclose total AUM, and no corroborating figure is available from the firm's own communications.

The firm's investment focus is almost entirely US-centric because its portfolio companies' primary customer is the US government. Veritas has occasionally held assets with international subsidiaries that serve allied governments, but the core thesis requires proximity to US defense, intelligence, and healthcare agencies. The firm has no offices outside New York and does not market funds to non-US limited partners as a strategic priority.

Veritas sales frequently require CFIUS review because portfolio companies hold sensitive US government contracts. The firm has developed repeated experience taking companies through CFIUS proceedings—an operational capability that becomes part of the value-creation story. Buyers must be approved by US regulators, which typically limits the pool to other US-headquartered strategic acquirers or clearance-qualified private equity firms.

Veritas avoids any business without a visible government revenue stream. The firm does not invest in consumer internet, enterprise SaaS without public-sector relevance, fintech serving purely commercial banking, or any company where classified contract work cannot provide competitive insulation. This negative screening means Veritas competes on a much narrower deal field than generalist technology or healthcare funds.

Yes, Veritas has co-invested on large transactions. The 2019 take-private of athenahealth was a joint acquisition with Evergreen Coast Capital, the private equity affiliate of Elliott Management. Veritas also co-led the Peraton acquisition of Perspecta in 2021. The firm will syndicate equity on deals that exceed single-fund concentration limits, but typically maintains control and operating governance.